Literature DB >> 2471971

Survival of hemopoietic progenitors in the G0 period of the cell cycle does not require early hemopoietic regulators.

A G Leary1, Y Hirai, T Kishimoto, S C Clark, M Ogawa.   

Abstract

Although it is generally held that hemopoietic stem cells in steady-state marrow are dormant in the cell cycle, the direct proof for this concept has been lacking. In the present study, we have documented the development of human multipotential blast cell colonies from single cells by daily observation of the growth of candidate progenitors. The results clearly demonstrated that early hemopoietic progenitors may remain as single cells for more than 2 weeks of incubation. Once the progenitors began proliferation, the subsequent growth was characterized by steady cell doubling. Next, we tested the survival of blast cell colony progenitors in the presence of neutralizing antibodies prepared against early acting hemopoietic factors including interleukin (IL) 1 alpha, IL-1 beta, IL-3, IL-6, and granulocyte colony-stimulating factor. Cultures were initiated with individual antibodies, and, on day 14, IL-3 and the corresponding growth factor in concentrations that neutralize the antibodies were added. On days 18-27 of culture, blast cell colonies containing 25 or more cells were identified and replated for analysis of their ability to form secondary colonies. The cumulative frequency of the blast cell colonies in cultures containing antibody did not differ significantly from that of the control group containing rabbit IgG. A combination of anti-IL-1 alpha, anti-IL-1 beta, anti-IL-6, and anti-granulocyte colony-stimulating factor did not affect the survival of dormant blast cell colony-forming cells. These results indicate that survival of hemopoietic stem cells in the G0 period of the cell cycle is independent of early hemopoietic regulators.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471971      PMCID: PMC287305          DOI: 10.1073/pnas.86.12.4535

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.

Authors:  L M Souza; T C Boone; J Gabrilove; P H Lai; K M Zsebo; D C Murdock; V R Chazin; J Bruszewski; H Lu; K K Chen; J Barendt; E Platzer; M A S Moore; R Mertelsmann; K Welte
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

2.  Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1.

Authors:  E R Stanley; A Bartocci; D Patinkin; M Rosendaal; T R Bradley
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

3.  Purification and characterization of recombinant human interleukin-1 beta produced in Escherichia coli.

Authors:  Y Kikumoto; Y M Hong; T Nishida; S Nakai; Y Masui; Y Hirai
Journal:  Biochem Biophys Res Commun       Date:  1987-08-31       Impact factor: 3.575

4.  Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  A G Leary; Y C Yang; S C Clark; J C Gasson; D W Golde; M Ogawa
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

5.  Blast cell colony assay for umbilical cord blood and adult bone marrow progenitors.

Authors:  A G Leary; M Ogawa
Journal:  Blood       Date:  1987-03       Impact factor: 22.113

6.  Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1.

Authors:  D Y Mochizuki; J R Eisenman; P J Conlon; A D Larsen; R J Tushinski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

Authors:  K Ikebuchi; G G Wong; S C Clark; J N Ihle; Y Hirai; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.

Authors:  M A Moore; D J Warren
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

9.  Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

Authors:  K Ikebuchi; S C Clark; J N Ihle; L M Souza; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

10.  Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha.

Authors:  A G Leary; K Ikebuchi; Y Hirai; G G Wong; Y C Yang; S C Clark; M Ogawa
Journal:  Blood       Date:  1988-06       Impact factor: 22.113

View more
  3 in total

1.  Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors.

Authors:  A G Leary; H Q Zeng; S C Clark; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis.

Authors:  M Z Ratajczak; W I Kuczynski; K Onodera; J Moore; J Ratajczak; D A Kregenow; K DeRiel; A M Gewirtz
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

3.  Stem cell origins of leukaemia and curability.

Authors:  M F Greaves
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.